PCN95 The Cost-Effectiveness of Aprepitant for the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy in Breast Cancer Patients Compared to Current Clinical Practice in Scotland
Abstract
Authors
E. Nikoglou S. Humphreys J. Pellissier C. O' Regan